In the 'Trajectory group characteristics' subsection of the Results, there is an error in the fourth sentence. The correct sentence is: There was no significant relationship between increasing HAQ trajectory group and death during follow-up, but some higher trajectory groups had greater proportion of patients who started a biologic (see [S1 Table](#pone.0231481.s001){ref-type="supplementary-material"}).

There are several errors in [S1 Table](#pone.0231481.s001){ref-type="supplementary-material"}. Please view the correct [S1 Table](#pone.0231481.s001){ref-type="supplementary-material"} below.

Supporting information {#sec001}
======================

###### Outcomes over follow-up, stratified by trajectory group.

† Hazard ratios calculated using Cox regression adjusted for age and gender.

‡ Group 2 chosen as reference category for biologic switching analysis, as group 1 only had one failure event, and this resulted in failures of the proportional hazards assumption. The proportional hazards assumption was met when group 2 was used as the reference category.

CI = confidence interval

bDMARD = biologic disease modifying anti-rheumatic drug.
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###### 

Click here for additional data file.
